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Summary
Post-term birth is a preventable cause of perinatal mortality and severe morbid-
ity. This review examined the association between maternal body mass index
(BMI) and post-term birth at ≥42 and ≥41 weeks’ gestation. Five databases,
reference lists and citations were searched from May to November 2015.
Observational studies published in English since 1990 were included. Linear
and nonlinear dose–response meta-analyses were conducted by using random
effects models. Sensitivity analyses assessed robustness of the results. Meta-
regression and sub-group meta-analyses explored heterogeneity. Obesity classes
were defined as I (30.0–34.9 kg m2), II (35.0–39.9 kg m2) and III (≥40 kg m2;
IIIa 40.0–44.9 kg m2, IIIb ≥ 45.0 kg m2). Searches identified 16,375 results,
and 39 studies met the inclusion criteria (n = 4,143,700 births). A nonlinear
association between maternal BMI and births ≥42 weeks was identified; odds
ratios and 95% confidence intervals for obesity classes I–IIIb were 1.42
(1.27–1.58), 1.55 (1.37–1.75), 1.65 (1.44–1.87) and 1.75 (1.50–2.04) respec-
tively. BMI was linearly associated with births ≥41 weeks: odds ratio is 1.13
(95% confidence interval 1.05–1.21) for each 5-unit increase in BMI. The
strength of the association between BMI and post-term birth increases with
increasing BMI. Odds are greatest for births ≥42 weeks among class III obesity.
Targeted interventions to prevent the adverse outcomes associated with
post-term birth should consider the difference in risk between obesity classes.
Keywords: BMI, gestational age, maternal, obesity.
Abbreviations: BMI, body mass index; CI, confidence interval; IQR, inter quartile
range; OR, odds ratio; RR, relative risk.
Introduction
Post-term birth is a preventable cause of intra-uterine death,
stillbirth, neonatal and infant death (1–4). Post-term birth
contributes to severe morbidities for the mother and child,
including macrosomia, shoulder dystocia, birth injury,
fourth degree perineal laceration, fetal compromise, antena-
tal and postpartum haemorrhage, fetal dysmaturity, labour
>24 h and newborn respiratory distress syndrome (1,5–7).
There is emerging evidence that primiparous women who
deliver post term have an increased risk of developing type
2 diabetes in later life (8). Costly obstetric and neonatal inter-
ventions associated with post-term birth include caesarean
section, induction of labour, operative vaginal delivery, close
fetal monitoring beyond term, ventilator use and neonatal in-
tensive care admission (1,7,9). The risks associated with
post-term birth have historically been under-estimated due
to self-reported assessment of gestational age relying on last
menstrual period. This self-report assessment over-estimates
post-term prevalence, resulting in an underestimate of the
risks of ‘true’ post-term birth due to lower-risk ‘term’ births
being misclassified as post-term (1,4,6). Current widespread
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use of ultrasound scan technology provides a more accurate
estimation of gestational age (10) and allows exploration of
the ‘true’ post-term risks.
Maternal obesity (i.e. pre-pregnancy body mass index
[BMI] ≥30 kg m2) impacts on daily clinical practice due
to the international rise in its prevalence and the complexity
of its comorbidities. Maternal obesity is a complex condi-
tion strongly associated with socio-economic status and
ethnicity inequalities, (11,12) making it a public health pri-
ority in addition to being a priority area for clinical practice.
For example, socio-economic status varies between obesity
classes, and pregnant women in the highest obesity class
(class III, BMI ≥40 kg m2) are significantly more likely to
reside in deprived locations (odds ratio [OR] 4.7, 95% con-
fidence interval [CI] 3.2–6.9) compared with women in obe-
sity class I (BMI 30.0–34.9 kg m2; OR 2.2, 95% CI 2.1–
2.3) (11). Disparities are also seen with maternal
employment status. Pregnant women with a BMI in class I
are more likely to be employed, while those in class III are
more likely to be unemployed (11). Obesity-associated
adverse pregnancy outcomes for the mother and child
include poorer mental health (13), gestational diabetes,
(14) congenital anomalies (15) and perinatal mortality
(2,16). Pre-pregnancy weight is the most significant
modifiable risk factor for stillbirth, with up to 100%
increased risk for women with obesity (22). There is increas-
ing evidence that maternal BMI influences gestational age at
delivery. Robust meta-analysis data demonstrate the
relationship between BMI and pre-term birth (17,18).
Despite published studies exploring the association between
maternal BMI and post-term birth (19–21), there is a lack of
robust evidence from meta-analyses.
Both maternal obesity and post-term birth are prevent-
able, and therefore warrant intervention to prevent associ-
ated adverse outcomes. Challenges to investigating
maternal obesity and post-term birth include interventions
to expedite birth, such as induction of labour and caesarean
section, interrupting the natural gestation trajectory. There
are differences in the definitions used to classify post-term
in existing literature, including pregnancies progressing
beyond 40, 41 or 42 weeks of gestation (4,6). Although
there is evidence of significantly increased risks for each
definition of post-term beyond 40 weeks (22), the greatest
risk is among the gestations >42 weeks for most adverse
outcomes (9). The terminologies post-term and prolonged
pregnancy are also used interchangeably to describe gesta-
tional ages beyond term (4).
Investigation of the association between maternal obesity
and post-term birth adds additional complexity. Maternal
obesity is associated with a significantly increased risk of
developing the comorbidities which lead to early interven-
tion and disrupts the natural pregnancy trajectory, including
gestational diabetes and preeclampsia (14,22). In addition,
the BMI definitions used to categorize maternal weight
status are used inconsistently, contributing to difficulty of
interpretation when making direct comparisons of studies.
The World Health Organization (WHO) criteria for catego-
rizing BMI are <18.5 kg m2 (underweight), 18.5–
24.9 kg m2 (recommended weight), 25.0–29.9 kg m2
(overweight) and ≥30.0 kg m2 (obese), with further obesity
sub-classes of class I 30.0–34.9 kg m2, class II 35.0–
39.9 kg m2 and class III ≥40 kg m2 obesity (23). For
Asian populations, the BMI criteria are reduced (recom-
mendedweight 18.5–23 kgm2, overweight 23–27.5 kgm2
and obese >27.5 kg m2) due to increased risk of metabolic
diseases at a lower BMI (24). However, the Asian-specific
definitions for weight status are not consistently adopted in-
ternationally in research or clinical guidelines.
Overcoming the methodological challenges to establish
the relationship between BMI and post-term birth is im-
portant to inform strategies for preventing associated ad-
verse outcomes, such as perinatal mortality and severe
morbidity. Additionally, identification of the dose–
response association would inform preconception and an-
tenatal healthcare planning, practice and guidelines such
as risk communication and shared decision-making for in-
tervention options for targeted groups of women based on
BMI. This systematic review and meta-analyses aimed to
establish the strength of the association between maternal
obesity and post-term birth. It specifically investigated the
dose–response association between BMI and post-term
birth, taking into consideration the methodological chal-
lenges, confounding and sources of heterogeneity in the
existing research.
Methods
Search strategies for systematic reviews of observational
epidemiological studies require multiple components as
database searches alone have been shown to only identify
up to half of the relevant literature (25). Systematic
exclusion of studies through following an inadequate search
strategy increases the risk of publication bias. Therefore, a
six-stage search strategy was followed in an attempt to limit
the effect of publication bias arising from searching
literature databases alone.
1. Databases were searched by using keywords and
study filters for non-randomized control trial studies.
Restrictions to human studies were included. Search
terms and subject headings were developed for
MEDLINE (Fig. 1) and translated across four addi-
tional databases: British Nursing Index, Cumulative
Index of Nursing and Allied Health, Embase and
PsycInfo (Fig. S1).
2. The reference lists of all included studies, and all
related systematic reviews identified in stage 1, were
hand searched.
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3. Citation searches for all included studies were
performed by using Google Scholar citation function.
4. Authors of relevant published abstracts were
contacted to identify if there had been subsequent full
publication of studies.
5. Any additional studies identified in stages 2–4 were
subject to further reference list and citation searching.
Stages 2–5 continued until no further new studies
were identified.
6. Authors of included studies were contacted for addi-
tional data when required for inclusion in the meta-
analyses.
Inclusion criteria were peer-reviewed full studies (i.e. not
abstracts, editorials, etc.), published in the English language
since 1 January 1990. Studies had to report both the
exposure variable (maternal weight status) and the outcome
variable (post-term birth). The six-stage search strategy was
carried out between May and November 2015. Screening
titles, abstracts and full papers for inclusion in the review
was carried out by two researchers independently. Data
extraction and quality assessment were also carried out
independently by two researchers by using a standardized
protocol for data extraction (Table S1) and the Newcastle–
Ottawa scale for cohort studies for quality assessment
(Fig S2). Independent extractions and assessments were
combined and agreed. A third researcher was available for
any disagreements (not required).
In circumstances where there were missing or unclear def-
initions for the exposure or outcome variables, or missing
Figure 1 MEDLINE database search.
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frequency data, the authors were contacted for clarification.
If the authors did not respond to the request for further
information after follow-up email requests, or if the authors
could not be contacted for any reason, then assumptions
about the definitions were made based on the information
provided in the papers. For example, if the study described
that they had compared post-term (defined as ≥42 weeks)
and pre-term (defined as <37 weeks) with term (undefined),
then the assumption was made that term was defined as the
gestational age between the reported post- and pre-term
(37 to 41 + 6 weeks). Alternative methods of making
assumptions included searching for definitions in papers
that the authors had referenced in relation to gestational
age or BMI and searching for any publications by the same
authors on a similar topic where they had defined the
variables. In the absence of any information to inform our
assumptions following these methods, the terminology used
by the authors was used to define the exposure and outcome
variables. For example, if the authors used the term ‘normal
BMI’, then the WHO criterion of 18.5–24.9 kg m2 was
assumed.
For the purposes of this systematic review, we catego-
rized post-term birth into two outcome variables which
were analysed separately. The primary outcome was
post-term birth ≥42 weeks of gestation as this gestation
incurs the greatest risk associated with post-term birth,
and the secondary outcome was post-term birth ≥41 weeks
of gestation as this gestation also has increased risk but to
a lesser extent than 42 weeks. Dose–response meta-
analyses were conducted to investigate the association
between maternal BMI and both outcomes. The study-
specific linear trends (ORs for continuous BMI assuming
linearity) were derived by using the method by Greenland
and Longnecker (26). This method requires the ORs with
CIs for at least two exposure categories (including the ref-
erence group) and the number of cases and participants in
each exposure category. If the adjusted ORs and CIs were
not available, then the respective unadjusted parameters
were derived from the data and used in the meta-analysis.
To assess the effect of including adjusted and unadjusted
ORs in the meta-analysis, subgroup meta-analyses were
performed with the studies that reported both adjusted
and unadjusted ORs (or provided data to enable unad-
justed ORs to be calculated), and the statistical signifi-
cance and direction of the associations were compared.
For each exposure category, the midpoint was calculated
as the average of the lower and upper bound, and the
respective OR was assigned to each midpoint. As the
BMI midpoint was required for these analyses, upper
and lower cut-offs were applied to open-ended BMI
categories in increments of 5 BMI units (e.g. for
BMI <18.5 kg m2, a 5 BMI unit lower limit of
13.5 kg m2 was applied; the respective midpoint was
16 kg m2). The regression coefficient for a change of 5
BMI units (log OR5BMI) is a function of the coefficient
estimated when assuming a change of 1 BMI unit (log
ORBMI), such that log OR5BMI = 5 × log ORBMI. The
summary ORs were calculated by using the random
effects model by DerSimonian and Laird (27).
A two-stage, random-effects, nonlinear dose–response
meta-analysis (28,29) was also conducted to assess po-
tential nonlinear associations, using cubic spline regres-
sion to model maternal BMI. The first stage involved
fitting a cubic spline model with two spline transforma-
tions, accounting for the correlation within each set of
published ORs. The two regression coefficients were
combined, and the variance/covariance matrices were es-
timated for each study by using a random-effects meta-
analysis. Nonlinearity was assessed by testing that the
coefficient of the second spline was equal to zero (30).
This method required ORs with CIs to be available for
at least three exposure (BMI) categories, as when only
two categories are reported (e.g. recommended and obese
BMIs), information on how the outcome behaves be-
tween the two categories is not available, and nonlinear-
ity cannot be assessed. Therefore, studies reporting data
for only two BMI categories were excluded from the
nonlinear analyses.
Publication bias was tested for using Eggers test (31).
A two-sided p-value <0.05 was considered statistically
significant. Sensitivity analyses were performed by sys-
tematically excluding one study at a time from the
meta-analysis. Meta-regression and sub-group meta-
analyses were carried out to explore factors identified a
priori as being potentially important sources of heteroge-
neity. A priori clinical factors were the method of assess-
ment of the exposure and outcome variables (maternal
weight and gestational age at delivery) and consideration
of the clinical confounders which impact on gestational
age at delivery (induction of labour, elective caesarean
section, parity, gestational diabetes, hypertension and
pre-eclampsia). No studies were excluded from the over-
all meta-analysis based on methodological factors such
as quality. However, methodological factors, including
quality as well as study size, geography, age and dura-
tion of the data included, study design (e.g. retrospective
or prospective, number of exposure categories and ad-
justed data) and how studies were identified for inclusion
in the review were explored by meta-regression and sub-
group meta-analysis. Heterogeneity among studies was
evaluated by using the I2 statistic (32) with a threshold
of >75% representing considerable heterogeneity (33).
The statistical analyses were conducted by using STATA
version 13.1. Studies which met the inclusion criteria
but did not present data suitable for inclusion in the
meta-analyses are summarized narratively. The
systematic review was registered on the PROSPERO
database (reference CRD42015014164).
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Results
Searches identified 16,375 studies, of which 39 met the
inclusion criteria, giving a total population of 4,143,700
births (Fig. 2, Table S2 for detailed information on screen-
ing). Of the included studies, 24 (62%) were identified
through database searches and 15 (38%) by searching refer-
ence lists and citations. Contacting authors of published ab-
stracts did not identify any additional eligible studies. Of the
39 included studies, 26 reported data for post-term birth
≥42 weeks, and 14 reported ≥41 weeks (see Table 1 for sum-
mary of included studies and Table S3 for additional detail).
Some studies provided data for both definitions of post-
term (Table 1). Twenty studies were from Europe, five each
from the USA and Middle East, four from Asia, three from
Canada and one each from South Africa and Australia.
Most studies were published between 2005 and 2014
(n = 33). Additional information was requested from the
authors on definitions used (e.g. BMI or gestational age
categories) or frequencies (e.g. number of cases or controls)
for 34 studies (Table S4). The quality of studies ranged from
a score of one to eight, with a median quality score of four
(Tables 1 and S4 for detailed quality assessment results).
There was negligible influence of using unadjusted or
adjusted ORs in the analysis of either post-term birth cate-
gories with a difference in OR of 0.03 when comparing
adjusted and unadjusted data from the same studies
(Fig. S3). Therefore, adjusted ORs were used when reported
and unadjusted ORs in the absence of adjusted data. One
study used the Asian-specific BMI reference criteria (34).
These data were transformed to represent the general popu-
lation BMI criteria with no influence on the overall effect
size (Fig. S4).
Nineteen studies reported data that could be pooled
for meta-analysis of post-term birth ≥42 weeks, and 11
studies reported data for post-term birth ≥41 weeks
(some studies reported multiple outcomes). Data from
10 studies could not be included in the meta-analysis,
and a narrative summary is provided for the results of
these studies.
Meta-analyses of post-term birth ≥42 weeks of
gestation
The 19 studies with data for ≥42-week meta-analysis in-
cluded 201,396 cases among 2,501,803 pregnancies
Figure 2 PRISMA flowchart of searches, screening and inclusion and exclusion of studies. [Colour figure can be viewed at wileyonlinelibrary.com]
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Table 1 Summary of included studies
Author, publication
year, country
Study
period
Gestational age
categories
(weeks)
BMI (kg m
2
)
or weight
categories
Crude analysis
(OR and 95% CI
unless specified)
Adjusted analysis
(OR and 95% CI
unless specified)
Quality score
(out of 8)
Abenhaim et al. 2007,41 Canada 04/1987–
03/1997
>37–42*
>42
20–24.9†
<19.9
25–29.9
30–39.9
>40
Not reported 1(1)
1.07 (0.86–1.33)
1.13 (0.89–1.45)
0.84 (0.55–1.28)
0.76 (0.19–3.10)
3
Al-Rayyan et al. 2010,42 Jordan 01/1990–
12/2000
37–41*
>42
<30†
≥30.0
Not reported Not reported 2
Arora et al. 2013,48 Thailand 02/2011–
08/2012
37–41*
42
18.5–24.9†
<18.5
25–29.9
≥30
Not reported Not reported 3
Arrowsmith et al. 2011,58 UK 01/2004–
12/2008
37–41
+2
*
41+3
20–24.9†
<19.9
25–29.9
30–34.9
35–39.9
>40
Not reported 1(1)
0.75 (0.66–0.85)
1.24 (1.14–1.34)
1.52 (1.37–1.70)
1.75 (1.48–2.07)
2.27 (1.78–2.86)
8
Basu et al. 2010,61
South Africa
02/2006 and
09/2006
37–41*
>41
18.5–24.9†
25–29.9
30–39.9
>40
Not reported Not reported 3
Bhattacharya 2007,63 UK 1976–2005 37–41*
>41
20–24.9†
<19.9
25–29.9
30–34.9
>35
1 (1)
0.7 (0.6–0.8)
1.2 (1.1–1.3)
1.4 (1.1–1.6)
0.8 (0.4–1.7)
1 (1)
0.9 (0.7–1.1)
0.9 (0.8–1.1)
0.9 (0.7–1.1)
0.8 (0.4–1.8)
5
Briese et al. 2011,38 Germany 1998–2000 Not reported 18.5–24.9
≥30
Not reported 1 (1)
1.45 (1.38–1.52)
4
Caughey et al. 2009,21 USA 01/1995–
12/1999
37–<41*
≥41
37–<42*
≥42
Not obese†
Obese
(BMI not defined)
Not reported 1 (1)
1.29 (1.18, 1.40)
1 (1)
1.20 (0.99, 1.46)
4
Cedergren 2004,49 Sweden 01/1992–
12/2001
37–41+6*
≥42
19.8–26†
29.1–35
35.1–40
>40
Not reported 1 (1)
1.37 (1.33–1.41)
1.49 (1.40–1.58)
1.80 (1.62–2.01)
5
Denison et al. 2008,39 Sweden 1998–2002 37–41+6*
≥42
20–25†
<20
25 < 30
30 < 35
≥35
Term median BMI 22.9
(IQR 21.025.3);
post-term median BMI 23.4
(IQR 21.5–26.0) p < 0.0001
Not reported 5
El-Gilany and Hammad 2010,50
Saudi Arabia
01/2007–12/
2007
37–42*
>42
18.5–24.9†
<18.5
25–29.9
≥30
RR (95% CI)1 (1)
2.3 (0.4–12.3)
2.0 (0.6–7.1)
3.7 (1.2–11.6)
Not reported 3
Halloran et al. 2012,19 USA 2000–2006 37–40*
=41
=42
18.5–24.9†
<18.5
25–29.9
≥30
Not reported Not reported 5
Johnson et al. 1992,51 USA 01/1987–
12/1989
38–42*
>42
<19.8†
19.8–26
27–29
>29
1 (1)
1.22 (0.89–1.66)
1.58 (1.03–2.4)
1.49 (1.01–2.2)
Not reported 5
Khashan and Kenny 2009,20
UK
01/2004–
12/2006
Not reported*
≥41
18.5–24.9†
<18.5
25–29.9
30–40
>40
1 (1)
0.79 (0.65–0.96)
1.13 (1.06–1.21)
1.28 (1.19–1.38)
1.17 (0.95–1.43)
1 (1)
0.81 (0.67–0.99)
1.17 (1.09–1.25)
1.35 (1.25–1.45)
1.24 (1.02–1.52)
5
(Continues)
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Table 1 (Continued)
Author, publication
year, country
Study
period
Gestational age
categories
(weeks)
BMI (kg m2)
or weight
categories
Crude analysis
(OR and 95% CI
unless specified)
Adjusted analysis
(OR and 95% CI
unless specified)
Quality score
(out of 8)
Kistka et al. 2007,40 USA 1989–1997 37–41
+6
*
≥42
Reference
not defined†
<20
>35
1 (1)
0.90 (0.88–0.93)
1.25 (1.19–1.32)
1 (1)
0.85 (0.82–0.87)
1.23 (1.16–1.29)
4
Kitiyodom and
Tongswatwong 2008,67 Thailand
10/2004–
09/2006
Reference
not defined†
Post-term not
defined
20–24.9†
>25
1 (1)
1.7 (1.19–2.44)
Not reported 3
Knight et al. 2010,68 UK 09/2007–
08/2008
Reference
not defined†
>42
<50†
≥50
1 (1)
1.31 (0.76–2.25)
1 (1)
1.35 (0.77–2.37)
4
Konje et al. 1993,72 UK 01/1989–
06/1990
37–42*
>42
17–24†
30.4–53.0
Not reported Not reported 4
Leung et al. 2008,34 Hong Kong 01/1995–
12/2005
37–40
+6
*
≥41
18.5–<23†
<18.5
≥23–<25
≥25–<27.5
≥27.5–<30
≥30
Not reported 1 (1)
0.84 (0.74–0.95)
1.06 (0.97–1.17)
1.21 (1.08–1.36)
1.25 (1.05–1.48)
1.34 (1.09–1.66)
4
Lumme et al. 1995,35 Finland 07/1985–
06/1986
37–41*
>41
19–24.9†
<19
25–29.9
≥30
Not reported 1 (1)
1.0 (0.7–1.4)
1.6 (1.2–2.1)
1.1 (0.6–1.9)
4
Mancuso et al. 1991,36 Italy Not reported 38–41*
>42
15.2–26.6†
>30
Not reported Not reported 1
Manzanares et al. 2012,37 Spain 2007–2009 37–41+2*
>41+3
18.5–25†
<18.5
>35
Not reported 1 (1)
0.81 (0.35–1.91)
0.72 (0.34–1.55)
4
Morgan et al. 2014,43 UK 11/2010–
02/2013
Reference
not defined†
= 42
18.5–24.9†
>25
1 (1)
2.18 (0.99–4.84)
Not reported 4
Navid et al. 2013,69 Pakistan 05/2011–
07/2012
37–40*
>40
18–24.9†
25–35
Not reported Not reported 2
Nohr et al. 2009,70 Denmark 1996–2002 37–41*
>41
15–33.3†
32.6–<35
35–<37.5
≥37.5
Not reported 1 (1)
1.3 (1.1–1.5)
1.5 (1.3–1.8)
1.4 (1.2–1.7)
4
Olesen et al. 2006,65 Denmark 1996–2004 37–41+6*
≥42
20–24†
<20
25–29
30–34
≥35
1
0.87
1.23
1.35
1.48
95% CI not reported
1 (1)
0.87 (0.80–0.94)
1.24 (1.15–1.34)
1.37 (1.22–1.54)
1.52 (1.28–1.82)
3
Raatikainen et al. 2006,53
Finland
01/1989–
12/2001
Reference
not defined†
>42
≤25†
26–29
≥30
Not reported Not reported 5
Robinson et al. 2005,37 Canada 01/1988–
12/1992
Reference
not defined†
> 41
55–75 Kg†
≥90–120 Kg
>120 Kg
1 (1)
1.10 (1.01–1.20)
0.91 (0.67–1.23)
1 (1)
1.18 (1.08–1.28)
0.99 (0.74–1.34)
4
Rode et al. 2005,54 Denmark 1998–2001 37–42*
>42
<25†
25–29.9
≥30
Not reported 1 (1)
1.4 (1.2–1.7)
1.4 (1.1–1.9)
5
Roos et al. 2010,55 Sweden 01/1992–
12/2006
37–41+6*
≥ 42
20–24.9†
<20
25–29.9
≥30
Not reported 1 (1)
0.74 (0.72–0.76)
1.31 (1.29–1.33)
1.63 (1.59–1.67)
8
(Continues)
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(8.1% incidence). In the dose–response analysis, the OR for
each 5 unit increase or decrease in BMI compared with the
reference BMI midpoint (22 kg m2) was 1.19 (95% CI
1.12–1.26; heterogeneity I2 = 98.1%, p < 0.001; Fig. 3a).
There was evidence of a nonlinear association (p = 0.002,
Table S6a and Fig. 3b) with a statistically significant
decrease in odds of births ≥42 weeks for underweight BMI
compared with the reference group and an increase for over-
weight and obese BMIs (Table 2). The odds of birth
≥42 weeks increased within obesity classes, with 42%,
55%, 65% and 75% increased odds for BMI classes I, II,
IIIa and IIIb respectively (Table 2). There was no evidence
of publication bias in the analyses of births ≥42 weeks
(p = 0.60, Table S7).
Meta-analyses of post-term birth ≥41 weeks of
gestation
The 11 studies with data for the meta-analysis of births
≥41 weeks included 70,334 cases among 444,706 pregnan-
cies (15.8% incidence). In the dose–response analysis, the
Table 1 (Continued)
Author, publication
year, country
Study
period
Gestational age
categories
(weeks)
BMI (kg m2)
or weight
categories
Crude analysis
(OR and 95% CI
unless specified)
Adjusted analysis
(OR and 95% CI
unless specified)
Quality score
(out of 8)
Schrauwers and Dekker 2009,62
Australia
01/2006–
06/2006
37–41*
>41
19.1–25†
25.1–30
30.1–40
>40
Not reported Not reported 2
Scott-Pillai et al. 2013,59 UK 2004–2011 Reference
not defined†
> 41
18.5–24.99†
<18.50
25–29.99
30–34.99
35–39.99
≥40
Not reported 1 (1)
0.5 (0.2–1.0)
0.9 (0.7–1.1)
0.8 (0.5–1.1)
0.9 (0.5–1.6)
0.8 (0.4–1.7)
7
Sharief and Tarik 2000,36 Iraq 12/1997–
08/1998
Reference
not defined†,
post-term not
defined
≤90 Kg
>90 Kg
Not reported Not reported 3
Stotland et al. 2007,56 USA 1990–2001 37–<41*
≥41
19.8–26†
<19.8
26.1–29
>29
Not reported 1 (1)
0.83 (0.72–0.95)
1.29 (1.10–1.52)
1.81 (1.50–2.18)
6
37–<42*
≥42
19.8–26†
<19.8
26.1–29
>29
1 (1)
0.78 (0.60–1.01)
1.51 (1.15–1.97)
1.69 (1.23–2.31)
Usha Kiran et al. 2005,44 UK 1990–1999 37–41*
>41
20–30†
>30
1 (1)
1.4 (1.2–1.7)
Not reported 4
Vaswani and Balachandran
2013,60 United Arab
Emirates
12/2010–
10/2011
37–41*
>41
18.5–24.9†
25–29.9
30–34.9
35–39.9
≥40
Not reported 1 (1)
1.54 (0.89–2.65)
1.69 (0.96–2.98)
1.78 (0.93–3.42)
2.99 (1.35–6.65)
4
Vinturache et al. 2014,57 Canada 05/2008–
12/2010
37–41+6*
≥42
18.5–24.99†
25–29.99
≥30
Not reported Not reported 5
Voigt et al. 2008,71 Germany 1998–2000 Term, not
defined†;
Post-term, not
defined
18.5–24.99†
40–44.99
≥45
Not reported Not reported 2
Yazdani et al. 2006,66 Iran 2008–2009 Term,
not defined†;
Post-term, not
defined
20–24.9†
≤19.9
25–29.9
30–34.9
>35
Not reported Not reported 2
†Reference group for BMI.
*Reference group for gestational age.
Abbreviations: BMI, body mass index; CI, confidence interval; IQR, inter quartile range; OR, odds ratio; RR, relative risk.
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OR for each 5 unit increase or decrease in BMI compared
with the reference BMI midpoint was 1.13 (95% CI 1.05–
1.21; heterogeneity I2 = 94%, p < 0.001; Fig. 4a). Linearity
of association between maternal BMI and birth ≥41 weeks
is not rejected (p = 0.23, Table S6b). Assuming a linear associ-
ation, this suggests a statistically significant decrease in odds
of births ≥41 weeks for underweight BMI compared with
the reference group and an increase for overweight and obese
BMIs (Table 2 and Fig. 4b). This increasing linear association
was also observed within the obesity classes, although to a
lesser extent than for births ≥42 weeks (26%, 39% and
52% increased odds for classes I, II and III respectively;
Table 2). There was no evidence of publication bias in the
analyses of births ≥41 weeks (p = 0.16, Table S7).
Sensitivity and heterogeneity analyses
Sensitivity analyses did not show any significant influence
on linearity of any individual studies in the linear analyses
for either post-term categories (Tables S8 and S9) or in the
Figure 3 Linear and nonlinear dose–response association between maternal body mass index and post-term birth ≥42 weeks: (3a) linear odds ratio per 5 ma-
ternal bodymass index units. The squares and lines through the squares represent the study-specific odds ratios and 95%confidence intervals. Thedimension of
the square is proportional to theweight of the study in themeta-analysis. Thediamond represents the summary odds ratio. (3b) nonlinear dose–response analysis.
[Colour figure can be viewed at wileyonlinelibrary.com]
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nonlinear analysis for births ≥42 weeks (Table S8). For
births ≥41 weeks, the sensitivity analyses for the nonlinear
model detected that data from one study(35) had an influ-
ence on linearity of the association between post-term birth
and maternal BMI (Table S9 and Fig. S5). The inclusion of
data from all studies visually appeared to be nonlinear
(Fig. S5); however, nonlinearity was not statistically signifi-
cant (p = 0.065, Table S6c). When the data from this one
study which was influencing linearity (35) were removed,
the results showed a linear trend (Fig. 4b).
Meta-regression exploring potential sources of heteroge-
neity identified that adjusting for the number of BMI expo-
sure categories had the greatest influence on overall
heterogeneity for births ≥42 weeks (I2 reduced by 22.2%,
from 98.1 to 75.95%, Table S10). Adjusting for additional
variables in the meta-regression did not have a substantial
impact on overall heterogeneity for either post-term out-
comes. Sub-group meta-analyses for post-term birth
≥42 weeks identified a significant reduction in heterogene-
ity (I2 < 75%, p > 0.05, ≥3 studies) in the following cate-
gories: having three or four exposure categories, sample
size between 1,000 and 10,000, controlling for induction
of labour or caesarean delivery and controlling for hyper-
tension or pre-eclampsia (Table S10). The most relevant in-
fluence on heterogeneity in the sub-group meta-analyses of
births ≥41 weeks was having four exposure categories
(Table S11).
Narrative summary of papers not included in the
meta-analysis
The 10 studies which had to be excluded from the meta-
analyses due to a lack of comparable data for pooling
included two studies only reporting maternal weight and
not BMI (36,37); five did not report frequency data for partic-
ipants and/or cases of post-term birth (21,38–41), and three
did not have comparable BMI reference groups (one com-
bined all non-obese (42), one combined underweight and
recommended weight (43), and one combined recommended
weight and overweight (44)). Of the 10 studies not included
in the meta-analyses, six found a significantly increased risk
of post-term birth in obese women compared with the refer-
ence group (21,37–40,44), while four did not find a signifi-
cantly increased association (36,41–43) (Table 3).
Discussion
This systematic review and meta-analyses of over 4 million
births have identified a significantly increasing association
between maternal BMI and post-term birth. This associa-
tion increases in strength as BMI increases, with a substan-
tial difference in effect size between obesity classifications:
a difference of 33% in odds of post-term birth ≥42 weeks
and 26% for ≥41 weeks when comparing obesity classes I
and III. This substantial increase in post-term birth and
associated risks for mothers in the highest obesity class
presents a double burden of inequality. Women facing the
greatest socio-economic disadvantage (11) also have the
highest level of pregnancy-related risk, confirming that
maternal obesity is both a clinical and public health priority
for the wellbeing of women and their babies.
The mechanisms linking maternal BMI and post-term birth
are not fully understood. The onset of labour involves me-
chanical and hormonal interactions between the mother,
foetus and placenta. The exact causal pathways remain
unclear, and much of the evidence is based on animal models.
This evidence suggests a number of potential mechanisms.
Hormones are thought to play a key role in the pathway,
including corticotrophin-releasing hormone, oestrogen, pro-
gesterone, prostaglandins and oxytocin (45). Additionally,
it is well established that women with obesity have increased
inflammation, circulating leptin concentrations, insulin resis-
tance, lipolysis and dyslipidaemia. These metabolic abnor-
malities have been hypothesized to influence the onset of
spontaneous or oxytocin-induced labour and uterine contrac-
tility (45). There is also evidence from one study in humans
Table 2 Odds ratios from linear and nonlinear dose-response analyses for maternal BMI and post-term birth
BMI Class (Midpoint BMI, kg/m
2
)
Post-term
category
Model Underweight
(17.5)
Reference
BMI (22.5)
Overweight
(27.5)
Obese I
(32.5)
Obese II
(37.5)
Obese IIIa
(42.5)
Obese IIIb
(47.5)
≥42 weeks Linear, OR
(95% CI)
0.84 (0.76,0.94) 1 1.19 (1.12,1.27) 1.38 (1.31,1.46) 1.57 (1.50,1.64) 1.76 (1.69,1.83) 1.95 (1.88,2.02)
≥42 weeks Nonlinear, OR
(95% CI)
0.81 (0.74,0.88) 1 1.24 (1.15,1.34) 1.42 (1.27,1.58) 1.55 (1.37,1.75) 1.65 (1.44,1.87) 1.75 (1.50,2.04)
≥41 weeks Linear, OR
(95% CI)
0.88 (0.83,0.95) 1 1.13 (1.05,1.21) 1.26 (1.18,1.34) 1.39 (1.31,1.47) 1.52 (1.44,1.54) ND
≥41 weeks Nonlinear, OR
(95% CI)
0.91 (0.85,0.97) 1 1.11 (1.04,1.20) 1.22 (1.07,1.39) 1.33 (1.10,1.59) 1.44 (1.13,1.83) ND
The midpoint generally corresponds to midpoints of World Health Organization BMI categories. Class III obese was divided into two sub-classes (a and b)
for the post-term ≥42 week analysis given that data were available. Two studies (52,72) were excluded from the nonlinear analyses as BMI was categorized
in two groups only. Abbreviations: BMI, body mass index; CI, confidence interval; ND, no data available; OR, odds ratio.
© 2017 The Authors. Obesity Reviews published by John Wiley & Sons Ltd
on behalf of World Obesity
Obesity Reviews 18, 293–308, March 2017
302 Maternal BMI and post-term birth N. Heslehurst et al. obesity reviews
that shows that women with diabetes (including type 1 diabe-
tes and gestational diabetes) had significantly reduced sponta-
neous myometrial contractility compared with women
without diabetes, even after stimulation with oxytocin (46).
Uterine biopsies identified reduced calcium channel expres-
sion and signalling among women with diabetes, and the au-
thors concluded that this was likely to account for the reduced
contractility in addition to a small but significant difference in
myometrial mass (46). As obesity and diabetes are closely re-
lated, further exploration ofmyometrial contractility between
women of different weight status’ could provide further evi-
dence for causal mechanisms of post-term birth and obesity.
The heterogeneity in the relationship between degree of
obesity and risk of post-term birth is an important message
Figure 4 Linear and nonlinear dose–response association between maternal BMI and post-term birth ≥41 weeks. (4a) Linear odds ratio per 5 maternal
body mass index units. The squares and lines through the squares represent the study-specific odds ratios and corresponding 95% confidence intervals.
The dimension of the square is proportional to the weight of the study in the meta-analysis. The diamond represents the summary odds ratio. (4b) Nonlinear
and linear dose-response analyses. analyses for post-term birth. Linear model with data from all included studies; nonlinear model following sensitivity
analysis and exclusion of Lumme et al. (35) (Fig. S5 and Table S9). [Colour figure can be viewed at wileyonlinelibrary.com]
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for researchers, practitioners and policy makers. The impli-
cation of using one criterion to define the obese population
is an attenuation of the true risk for the higher obesity
classes. Despite the differences between obesity classes,
pregnancy outcome data are often reported for one obese
category. When pregnancy outcomes are reported by
obesity class, a similar pattern is often reported. For exam-
ple, the odds of pre-term birth were reported to increase
twofold from 1.6 (95% CI 1.4–1.8) for class I to 3.0
(95% CI, 2.3–3.9) for class III obesity (47). Similarly, the
odds of GDM increased from 3.0 (95% CI 2.3–3.9) for
class I to 5.6 (95% CI 4.3–7.2) for class III obesity (14).
However, differentiating between obesity classes can be
challenging. Although class III obesity is increasing at the
most rapid rate over time (11), it only represents approxi-
mately 1% of pregnancies in the UK (11) and 4% in the
USA (12). For population data to be powered for statistical
significance, the sample size needs to be sufficient to detect
enough cases in each obesity class. Our sub-group meta-
analyses suggest that 100 cases of post-term birth ≥42 weeks
and 1000 cases for ≥41 weeks are required to detect signif-
icance, which may not always be feasible, even in national-
level datasets. When obesity classifications have to be
combined for statistical power, there should be cautious
interpretation of the results reflecting ‘obesity’ without con-
sideration of the heterogeneous nature of obesity classifica-
tions. Additionally, the use of Asian-specific rather than
general population BMI criteria should be considered in fu-
ture research. Although we did not identify any impact of
using either definition on post-term birth in this review,
our analyses were limited as only one study had utilized
the Asian-specific criteria.
There are similar challenges with inconsistent use of post-
term birth categories. Meta-analyses showed an increased
association with maternal BMI and both post-term catego-
ries and the highest odds for births ≥42 weeks. Although
Table 3 Results of the studies included in the narrative summary
Study Country
of study
Sample
size
Maternal weight
exposure variable*
Post-term
variable
Results Association
with obesity
Primary reason
not included in
meta-analysis
Abenhaim
et al.
200741
Canada 18,633 R: BMI 20 to 24.9;
O1: BMI 30 to 39.9;
O2: BMI >40
>42 weeks O1: AOR 0.84 (95% CI
0.55–1.28); O2: AOR 0.76
(95% CI 0.19–3.10)
Frequency data not provided
No significant
difference
No frequency data
provided
Al-Rayyan
et al.
201042
Jordan 1,008 R: BMI <30;
O: BMI >30
>42 weeks R: n = 55, 10.6%;
O: n = 54, 11.0%;
Statistical analysis not reported
No difference Non-comparable BMI
reference group
Briese
et al.
201138
Germany 243,571 R: BMI 18.5 to 24.9;
O: BMI ≥30
Not defined AOR 1.45 (95% CI 1.38–1.52)
Frequency data not provided
Significantly
increased
No frequency data
provided
Caughey
et al.
200921
USA 119,162 R: ‘Not obese’;
O: ‘Obese’
Not defined
≥41 weeks and
≥42 weeks
≥41 weeks AOR 1.26 (95% CI
1.16–1.37); ≥42 weeks AOR
1.20 (95% CI 0.99–1.46)
Frequency data not provided
Significantly
increased
(41 weeks
only)
No frequency data
provided; non-
comparable BMI
reference group
Denison
et al.
200839
Sweden 143,519 R: BMI 20 to <25;
O1: BMI 30 to <35;
O2: BMI ≥35
≥294 d
(42 weeks)
Higher maternal BMI in 1st
trimester increased post-term
(p < 0.001)
Significantly
increased
No frequency data
provided
Kistka
et al.
200740
USA 368,633 R: not defined;
O: BMI >35
≥42 weeks AOR 1.23 (95% CI 1.16–1.29)
Frequency data not provided
Significantly
increased
No frequency data
provided
Mancuso
et al.
199136
Italy 160 R: BMI 15.2–26.6;
O: BMI >30
>42 weeks R: n = 1O: n = 3
p > 0.05
No significant
difference
Non-comparable BMI
reference group
Robinson
et al.
200537
Canada 142,404 R: 55 to 75 kg;
O1: 90 to 120 kg;
O2: >120 kg
>41 weeks R: n = 4997, 6.3%;
O1: n = 647, 6.9%;
AOR 1.18 (95% CI 1.08–1.28);
O2: n = 45, 5.8%;
AOR 0.99 (95% CI 0.74–1.34)
Significantly
increased (O1
only)
Maternal exposure
weight
Sharief
et al.
200036
Iraq 40 R: ≤90 kg;
O: >90 kg
Not defined R: n = 3, 15%; O: n = 3, 15%
Statistical analysis not reported
No difference Maternal exposure
weight
Usha
Kiran et al.
200544
Wales 8,350 R: BMI 20 to 30;
O: BMI >30
>41 weeks R: n = 2490, 32.5%;
O: n = 278, 41.0%, OR 1.4
(95% CI 1.2–1.7)
Significantly
increased
Non-comparable BMI
reference group
Abbreviations: AOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; O, obese weight group; OR, odds ratio; R, reference weight
group.
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there is significantly increased risk for pregnancies
progressing beyond 40 weeks (22), the greatest risk is in
pregnancies with gestations ≥42 weeks (9), particularly for
perinatal mortality and severe morbidities which require
obstetric and neonatal intervention. Studies which combine
post-term birth categories are likely to underestimate the
level of risk associated with maternal BMI.
A key strength of this review is overcoming the methodo-
logical challenges of investigating post-term birth and
maternal BMI. Analyses were performed throughout to
explore the influence of methodological decisions, such as
using unadjusted data and Asian-specific BMI categories.
The conversion of categorical BMI was necessary due to
limited reporting of directly comparable obesity categories:
17 studies combined data for obesity classes I–III
(19,34,35,38,42–44,48–57), three reported obesity classes
I–III separately (58–60), four combined obesity classes I
and II (20,41,61,62), six combined classes II and III
(39,40,63–66), seven had further inconsistent non-
comparable categories such as combining overweight and
obese (36,37,67–71), and two studies did not define their
BMI categories (21,72). The possible groups to combine
for categorical analyses would have been further reduced
when applying additional analysis criteria such as the gesta-
tional age stratification, definition of the reference BMI
group, etc. Therefore, the conversion to continuous BMI
allowed direct comparison of more studies overall than
would have been possible by using a categorical meta-
analysis. To aid the interpretation of continuous BMI
analyses, increments of 5 BMI units were used to allow
back-translation to approximate WHO categories. This
allows for international comparison with other published
research on maternal BMI and facilitates interpretation for
clinical practice, public health and policy-maker decisions
which have a tendency to utilize BMI categories.
A further strength of this systematic review is the rigorous
search strategy. It has been demonstrated that database
searches alone are not sufficient for epidemiology systematic
reviews (25), and the Meta-analysis of Observational
Studies in Epidemiology guidelines (73) recommend that
additional searches may be necessary. We performed rigor-
ous database searches including pilot and refinement of
the search strategy by the research team, including an infor-
mation scientist with expertise in database searching. This
was supplemented by additional searches in our six-stage
search strategy to identify the full evidence base. Among
the studies identified by using additional search methods,
some were published in journals not indexed on the biblio-
graphic databases and therefore would not have been
identified by database searches alone. Furthermore, the
post-term data presented in a number of studies were not
a primary outcome, rather one outcome among multiple
adverse pregnancy outcomes being investigated. These stud-
ies did not include the post-term search terms in the
keywords, titles or abstracts and therefore would not have
been identified by any search strategy using these terms.
This rigorous search strategy was time consuming, al-
though it resulted in an absence of publication bias. The
method of searching (i.e. database, reference list or citation
searches) was an a priori factor considered in the sub-
group meta-analysis and meta-regression to explore
sources of heterogeneity between studies. While the
method of searching did not impact on overall heterogene-
ity, the subgroup analyses suggest that the inclusion of
studies identified through database searches was more
likely to show statistically significant results in meta-
analysis than the studies identified by the additional
searches (see Table S10 for example of analysis on post-
term ≥42 weeks). This result could have been due to more
studies being included in the ≥42-week sub-group meta-
analysis identified by database searches (n = 12) compared
with citation searches (n = 4) or reference list searches
(n = 3). However, it could also suggest that database
searches alone would result in positive publication bias
by only identifying those studies more likely to show sta-
tistical significance. This result supports the Meta-analysis
of Observational Studies in Epidemiology guideline recom-
mendation for supplementing database searches when car-
rying out systematic reviews of observational studies.
A limitation of systematic review methodology is reli-
ance on the availability of published data which can im-
pact on the analyses. The use of self-reported last
menstrual period or measured ultrasound scan is an im-
portant clinical factor influencing the assessment of gesta-
tional age, yet five studies did not specify methods of
assessment for the ≥42 week meta-analysis and a further
seven for ≥41 weeks. Meta-regression identified some fac-
tors considered to be important a priori which did not im-
pact on the results, such as the use of self-report or
measured BMI. The use of self-reported BMI among obese
BMI groups is a frequent methodological criticism (74),
yet had little influence in our meta-regression analyses.
Others have reported that the error caused by self-report
misclassification of BMI among overweight and obese
women has minimal influence on the dose–response analy-
ses for large for gestational age, gestational diabetes and
preeclampsia (75). Therefore, the potential under-reporting
of self-reported BMI appears to have little influence on
large-scale epidemiological analysis of maternal weight sta-
tus and pregnancy outcomes. Additionally, 25 of the in-
cluded studies did not report the ethnicity of their
population and therefore, we could not explore this in
the meta-regression or sub-group analysis which makes
the generalizability across ethnicities challenging. How-
ever, one quarter of the studies were from the Middle East,
Asia or South Africa which suggests that there was some
ethnic diversity present in the populations rather than data
originating from mainly White populations. Of the studies
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that reported ethnicity, eight studies described their popu-
lation as mainly White, one as all Asian, one as mainly
African, and four described a mix of ethnic groups in the
population. The meta-regression did explore country of
study, and this did not impact on overall heterogeneity
of results.
Maternal obesity is increasing internationally, and the
daily challenges for clinical and public health practice will
also continue to increase. The results of this systematic re-
view and meta-analyses add to the evidence-base of in-
creased risks associated with maternal obesity and can be
used to inform preconception and pregnancy care. Policy
makers should emphasize the importance of supporting
women to reduce their BMI preconception and inter-
pregnancy to prevent the adverse outcomes associated with
post-term birth, such as perinatal and infant mortality. The
increasing dose–response association also informs
healthcare planning and commissioning of services, as the
level and intensity of intervention required to prevent ad-
verse outcomes associated with post-term birth will differ
according to BMI class. The data can also be used to inform
the need for interventions such as induction of labour and
caesarean delivery to prevent pregnancies progressing to
post-term. These procedures in obese populations also pres-
ent clinical challenges and require increased planning,
evidence-based risk communication and shared decision-
making about birth plans. Any steps taken to support the
health and wellbeing of women and their babies in relation
to post-term birth and associated risks should be informed
by the dose–response association between the obesity clas-
ses. Further research which utilizes maternal BMI should
also consider the heterogeneity within obesity populations
and the need for adequately powered studies to explore
pregnancy outcomes in the higher, less prevalent, obesity
classes.
Conclusions
Maternal obesity is having a significant impact on daily clin-
ical practice. The association between maternal BMI and
post-term birth increases with increasing BMI, with the
greatest odds among women in obesity class III and with
post-term birth ≥42 weeks. Pregnancies which progress be-
yond 42 weeks have significantly increased risk of adverse
outcomes, including perinatal mortality. This presents a
double burden of disease among women with morbid obe-
sity, which is also associated with the highest levels of
socio-economic disadvantage compared with other BMI
categories. Future maternal obesity research should con-
sider the heterogeneity between obesity classes. Healthcare
policy and practice should ensure that necessary interven-
tions are in place to prevent the adverse outcomes associ-
ated with post-term birth, considering the increased risk
among the higher obesity classes.
Acknowledgements
All authors contributed to the design of the research, acqui-
sition of data and writing of the manuscript. NH and JR ob-
tained funding. NH, RV and LH carried out the analysis.
The authors would like to acknowledge Dr Helen Simpson
at South Tees Hospitals NHS Foundation Trust and Dr
Helene Brandon at Gateshead NHS Foundation Trust for
their contribution to the clinical relevance and interpreta-
tion of this study. Dr Simpson and Dr Brandon are consul-
tant obstetricians with a special interest in maternal
obesity and risk management.
This research was part funded by a Medical Research
Council and Newcastle University Faculty of Medical
Sciences Doctoral Training award for ES. The funders had
no role in design and conduct of the study, collection,
management, analysis and interpretation of the data and
preparation, review or approval of the manuscript.
Conflict of interest statement
Dr Heslehurst has nothing to disclose.
Dr Vieira has nothing to disclose.
Dr Hayes has nothing to disclose.
Dr Crowe has nothing to disclose.
Mr Jones has nothing to disclose.
Ms Robalino has nothing to disclose.
Ms Slack has nothing to disclose.
Prof. Rankin has nothing to disclose.
Supporting information
Additional Supporting Information may be found in the
online version of this article, http://dx.doi.org/10.1111/
obr.12489
Figure S1. Translation of search terms across databases.
Figure S2. Adapted Newcastle-Ottawa Scale.
Figure S3. Exploration of the use of adjusted or unadjusted
data for post-term birth (≥ 42 weeks and ≥41 weeks) meta-
analysis.
Figure S4. Sensitivity analysis for transforming Asian-spe-
cific BMI reference criteria for the analysis of maternal
BMI and post-term birth (≥41 weeks gestation) using
Asian-specific BMI criteria for Leung et al. 2008.
Figure S5. Nonlinear dose-response analysis for maternal
BMI and post-term birth ≥41 weeks, including all studies.
Table S1. Data extraction protocol.
Table S2. Screening: systematic review reference lists
screened, and full papers screened and excluded.
Table S3. Details of included studies.
Table S4. Contacting authors for additional information.
Table S5. Quality scores for all included studies.
Table S6. Nonlinear meta-analyses using cubic splines re-
gression.
© 2017 The Authors. Obesity Reviews published by John Wiley & Sons Ltd
on behalf of World Obesity
Obesity Reviews 18, 293–308, March 2017
306 Maternal BMI and post-term birth N. Heslehurst et al. obesity reviews
Table S7. Egger’s test for publication bias for post-term
birth: ≥ 42 weeks and ≥41 weeks.
Table S8. Maternal BMI and post-term birth ≥42 weeks
sensitivity analysis.
Table S9. Maternal BMI and post-term birth ≥41 weeks
sensitivity analysis.
Table S10. Meta-regression results for post-term birth ≥42
weeks.
Table S11. Meta-regression results for post-term birth ≥41
weeks.
References
1. Spong CY. Defining “term” pregnancy: recommendations from
the defining “term” pregnancy workgroup. JAMA. 2013; 309:
2445–2446.
2. Flenady V, Koopmans L, Middleton P et al. Major risk factors
for stillbirth in high-income countries: a systematic review and
meta-analysis. The Lancet. 2011; 377: 1331–1340.
3. Caughey AB, Musci TJ. Complications of term pregnancies be-
yond 37 weeks of gestation. Obstetrics & Gynecology. 2004;
103: 57–62.
4. Shea KM, Wilcox AJ, Little RE. Postterm delivery: a challenge
for epidemiologic research. Epidemiology. 1998; 9: 199–204.
5. Mandruzzato G, Alfirevic Z, Chervenak F et al. Guidelines for
the management of postterm pregnancy. Journal of Perinatal
Medicine. 2010; 38: 111–119.
6. Caughey AB, Snegovskikh VV, Norwitz ER. Postterm preg-
nancy: how can we improve outcomes? Obstetrical &
Gynecological Survey. 2008; 63: 715–724.
7. Caughey AB, Bishop JT. Maternal complications of pregnancy
increase beyond 40 weeks of gestation in low-risk women. Journal
of Perinatology. 2006; 26: 540–545.
8. James-Todd TM, Karumanchi SA, Hibert EL et al. Peer
reviewed: gestational age, infant birth weight, and subsequent risk
of type 2 diabetes in mothers: Nurses’ Health Study II. Preventing
Chronic Disease. 2013; 10.
9. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Mater-
nal and obstetric complications of pregnancy are associated with
increasing gestational age at term. American Journal of Obstetrics
and Gynecology 2007; 196(155) e1-55. e6.
10. Caughey AB, Nicholson JM, Washington AE. First- vs second-
trimester ultrasound: the effect on pregnancy dating and perinatal
outcomes. American Journal of Obstetrics & Gynecology 2008;
198: 703.e1–703.e6.
11. Heslehurst N, Rankin J, Wilkinson JR, Summerbell CD. A na-
tionally representative study of maternal obesity in England, UK:
trends in incidence and demographic inequalities in 619 323 births,
1989–2007. International Journal of Obesity. 2010; 34: 420–428.
12. Fisher SC, Kim SY, Sharma AJ, Rochat R, Morrow B. Is
obesity still increasing among pregnant women? Prepregnancy
obesity trends in 20 states, 2003–2009. Preventive Medicine.
2013; 56: 372–378.
13. Molyneaux E, Poston L, Ashurst-Williams S, Howard LM.
Obesity and mental disorders during pregnancy and postpartum:
a systematic review and meta-analysis. Obstetrics & Gynaecology.
2014; 123: 857–867.
14. Torloni MR, Betrán AP, Horta BL et al. Prepregnancy BMI and
the risk of gestational diabetes: a systematic review of the literature
with meta-analysis. Obesity Reviews. 2008; 10: 194–203.
15. Stothard KJ, Tennant PWG, Bell R, Rankin J. Maternal
overweight and obesity and the risk of congenital anomalies: a
systematic review and meta-analysis. JAMA. 2009; 301:
636–650.
16. Aune D, Saugstad O, Henriksen T, Tonstad S. Maternal body
mass index and the risk of fetal death, stillbirth, and infant death: a
systematic review and meta-analysis. JAMA. 2014; 311: 1536–1546.
17. McDonald SD, Han Z, Mulla S, Beyene J. Overweight and
obesity in mothers and risk of preterm birth and low birth weight
infants: systematic review and meta-analyses. BMJ. 2010; 341.
18. Torloni MR, Betran AP, Daher S et al.Maternal BMI and pre-
term birth: a systematic review of the literature with meta-analysis.
The Journal of Maternal-Fetal and Neonatal Medicine. 2009; 22:
957–970.
19. Halloran DR, Cheng YW, Wall TC, Macones GA, Caughey
AB. Effect of maternal weight on postterm delivery. Journal of
Perinatology. 2012; 32: 85–90.
20. Khashan AS, Kenny LC. The effects of maternal body mass
index on pregnancy outcome. European Journal of Epidemiology.
2009; 24: 697–705.
21. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who
is at risk for prolonged and postterm pregnancy? American Journal
of Obstetrics & Gynecology 2009; 200(683) e1-83. e5.
22. Greve T, Lundbye-Christensen S, Nickelsen CN, Secher NJ.
Maternal and perinatal complications by day of gestation after
spontaneous labor at 40–42 weeks of gestation. Acta Obstetricia
et Gynecologica Scandinavica. 2011; 90: 852–856.
23. World Health Organisation. Obesity: Preventing and Manag-
ing the Global Epidemic. WHO: Geneva, 2004.
24. World Health Organisation. Expert consultation: appropriate
body-mass index for Asian populations and its implications for pol-
icy and intervention strategies. Lancet. 2004; 363: 157–163.
25. Chalmers I, Dickersin K, Chalmers TC. Getting to grips with
Archie Cochrane’s agenda. BMJ. 1992; 305: 786–788.
26. Greenland S, LongneckerMP.Methods for trend estimation from
summarized dose–response data, with applications to meta-analysis.
American Journal of Epidemiology. 1992; 135: 1301–1309.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Con-
trol Clinical Trials. 1986; 7: 177–188.
28. Orsini N, Bellocco R, Greenland S. Generalized least squares
for trend estimation of summarized dose–response data. Stata J.
2006; 6: 40–57.
29. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-
analysis for linear and nonlinear dose–response relations: examples,
an evaluation of approximations, and software. American Journal
of Epidemiology. 2012; 175: 66–73.
30. Desquilbet L, Mariotti F. Dose–response analyses using
restricted cubic spline functions in public health research. Statistics
in Medicine. 2010; 29: 1037–1057.
31. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-
analysis detected by a simple, graphical test. BMJ 1997; 315:
629–634.
32. Higgins JP, Thompson SG. Quantifying heterogeneity in a
meta-analysis. Statistics in Medicine. 2002; 21: 1539–1558.
33. Higgins JPT, Green S. Cochrane Handbook for Systematic Re-
views of Interventions Version 5.1.0. [updated March 2011] The
Cochrane Collaboration, 2011.Available from www.cochrane-
handbook.org
34. Leung TY, Leung TN, Sahota DS et al. Trends in maternal obe-
sity and associated risks of adverse pregnancy outcomes in a
population of Chinese women. BJOG: An International Journal
of Obstetrics & Gynaecology. 2008; 115: 1529–1537.
35. Lumme R, Rantakallio P, Hartikainen AL, Jarvelin MR. Pre-
pregnancy weight and it’s relation to pregnancy outcome. Obstet-
rics & Gynaecology. 1995; 15: 69–75.
36. Sharief M, Tarik A. Obesity in pregnancy. Qatar Medical
Journal. 2000; 9: 48–50.
© 2017 The Authors. Obesity Reviews published by John Wiley & Sons Ltd
on behalf of World Obesity
Obesity Reviews 18, 293–308, March 2017
Maternal BMI and post-term birth N. Heslehurst et al. 307obesity reviews
37. Robinson H, O’Connell C, Joseph K, McLeod N. Maternal
outcomes in pregnancies complicated by obesity. Obstetrics & Gy-
necology. 2005; 106: 1357–1364.
38. Briese V, Voigt M, Wisser J, Borchardt U, S S. Risks of preg-
nancy and birth in obese primiparous women: an analysis of
German perinatal statistics. Archives of Gynecology and Obstet-
rics. 2011; 283: 249–253.
39. Denison FC, Price J, Graham C, Wild S, Liston WA. Maternal
obesity, length of gestation, risk of postdates pregnancy and sponta-
neous onset of labour at term. BJOG: An International Journal of
Obstetrics and Gynaecology. 2008; 115: 720–725.
40. Kistka ZAF, Palomar L, Boslaugh SE, DeBaun MR, DeFranco
EA, Muglia LJ. Risk for postterm delivery after previous postterm
delivery. American Journal of Obstetrics& Gynecology 2007;
196(241) e1-41.e6.
41. Abenhaim HA, Kinch RA, Morin L, Benjamin A, Usher R.
Effect of prepregnancy body mass index categories on obstetrical
and neonatal outcomes. Archives of Gynecology & Obstetrics.
2007; 275: 39–43.
42. Al-Rayyan E, Shwayat R, AL-Sumadi A et al. The effect of high
maternal body mass index before pregnancy on pregnancy out-
come. Journal of the Royal Medical Services. 2010; 17: 11–15.
43. Mancuso A, D’Anna R, Leonardi R. Pregnancy in the obese
patient. European Journal of Obstetrics and Gynecology and Re-
productive Biology. 1991; 39: 83–86.
44. Usha Kiran TS, Hemmadi S, Bethel J, Evans J. Outcome of
pregnancy in a woman with an increased body mass index. BJOG:
An International Journal of Obstetrics & Gynaecology. 2005; 112:
768–772.
45. Bogaerts A, Witters I, Van den Bergh BR, Jans G, Devlieger R.
Obesity in pregnancy: altered onset and progression of labour.Mid-
wifery. 2013; 29: 1303–1313.
46. Al-Qahtani S, Heath A, Quenby S et al. Diabetes is associated
with impairment of uterine contractility and high caesarean section
rate. Diabetologia. 2012; 55: 489.
47. Cnattingius S, Villamor E, Johansson S et al. Maternal obesity
and risk of preterm delivery. JAMA. 2013; 309: 2362–2370.
48. Arora R, Arora D, Patumanond J. Adverse pregnancy
outcomes in women with high pre-pregnancy body mass index.
Open Journal of Obstetrics and Gynecology. 2013; 3: 285–291.
49. Cedergren MI. Maternal morbid obesity and the risk of adverse
pregnancy outcome.Obstetrics & Gynecology. 2004; 103: 219–224.
50. El-Gilany AH, Hammad S. Body mass index and obstetric out-
comes in pregnant in Saudi Arabia: a prospective cohort study.
Annals of Saudi Medicine 2010; 30: 376 .80+421
51. Johnson JW, Longmate JA, Frentzen B. Excessive maternal
weight and pregnancy outcome. American Journal of Obstetrics
& Gynecology. 1992; 167: 353–370.
52. Morgan KL, Rahman MA, Hill RA et al. Physical activity and
excess weight in pregnancy have independent and unique effects on
delivery and perinatal outcomes. PLoS ONE. 2014; 9 .e94532
53. Raatikainen K, Heiskanen N, Heinonen S. Transition from
overweight to obesity worsens pregnancy outcome in a BMI-
dependent manner. Obesity 2006; 14: 165–171.
54. Rode L, Nilas L, Wojdemann K, Tabor A. Obesity-related
complications in Danish single cephalic term pregnancies. Obstet-
rics & Gynecology. 2005; 105: 537–542.
55. Roos N, Sahlin L, Ekman-Ordeberg G, Kieler H, Stephansson
O. Maternal risk factors for postterm pregnancy and cesarean de-
livery following labor induction. Acta Obstetricia et Gynecologica
Scandinavica. 2010; 89: 1003–1010.
56. Stotland NE, Washington AE, Caughey AB. Prepregnancy
body mass index and the length of gestation at term. American
Journal of Obstetrics & Gynecology 2007; 197: 378.e1–378.e5.
57. Vinturache A,Moledina N,McDonald S, Slater D, Tough S. Pre-
pregnancy body mass index (BMI) and delivery outcomes in a Cana-
dian population. BMC Pregnancy & Childbirth. 2014; 14: 1–10.
58. Arrowsmith S, Wray S, Quenby S. Maternal obesity and la-
bour complications following induction of labour in prolonged
pregnancy. BJOG: An International Journal of Obstetrics and Gy-
naecology. 2011; 118: 578–588.
59. Scott-Pillai R, Spence D, Cardwell CR, Hunter A, Holmes VA.
The impact of body mass index on maternal and neonatal out-
comes: a retrospective study in a UK obstetric population, 2004–
2011. BJOG: An International Journal of Obstetrics and Gynaecol-
ogy. 2013; 120: 932–939.
60. Vaswani PR, Balachandran L. Pregnancy outcomes in a popu-
lation with high prevalence of obesity: how bad is it? Clinical
Epidemiology and Global Health. 2013; 1: 5–11.
61. Basu JK, Jeketera CM, Basu D. Obesity and its outcomes
among pregnant South African women. International Journal of
Gynecology and Obstetrics. 2010; 110: 101–104.
62. Schrauwers C, Dekker G. Maternal and perinatal outcome in
obese pregnant patients. Journal of Maternal-Fetal & Neonatal
Medicine. 2009; 22: 218–226.
63. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Ef-
fect of body mass index on pregnancy outcomes in nulliparous
women delivering singleton babies.BMCPublic Health. 2007; 7: 168.
64. Sebastián Manzanares G, Ángel Santalla H, Irene Vico Z,
López Criado MS, Alicia Pineda L, José Luis Gallo V. Abnormal
maternal body mass index and obstetric and neonatal outcome.
The Journal of Maternal-Fetal & Neonatal Medicine. 2012; 25:
308–12.
65. Olesen AW,Westergaard JG, Olsen J. Prenatal risk indicators of
a prolonged pregnancy. The Danish Birth Cohort 1998–2001. Acta
Obstetricia et Gynecologica Scandinavica. 2006; 85: 1338–1341.
66. Yazdani S, Yosofniyapasha Y, Nasab BH, Mojaveri MH,
Bouzari Z. Effect of maternal body mass index on pregnancy out-
come and newborn weight. BMC Research Notes. 2012; 5: 1–4.
67. Kitiyodom S, Tongswatwong P. Pregnancy outcomes of parturi-
ents with excessive-weight in Maharat Nakorn Ratchasima Hospital.
Thai Journal of Obstetrics and Gynaecology. 2008; 16: 214–220.
68. Knight M, Kurinczuk JJ, Spark P, Brocklehurst P, System
UKOS. Extreme obesity in pregnancy in the United Kingdom. Ob-
stetrics & Gynecology. 2010; 115: 989–997.
69. Navid S, Arshad S, Atif K, Arshad MR. Impact of high mater-
nal body mass index on length of gestation and maternal delivery
outcomes. Rawal Medical Journal. 2013; 38: 279–282.
70. Nohr EA, Timpson NJ, Andersen CS, Smith GD, Olsen J,
Sorensen TIA. Severe obesity in young women and reproductive
health: The Danish national birth cohort. PLoS ONE. 2009; 4.
71. Voigt M, Zygmunt M, Henrich W, Straube S, Carstensen M, B
V. Analysis of subgroup of pregnant women in Germany. Geburtsh
Frauenheilk 16th communication: morbid obesity: pregnancy risks,
birth risks and status of the newborn 2008; 68: 794–800.
72. Konje JC, Imrie A, Hay DM. Pregnancy in obese women.
Journal of Obstetrics & Gynaecology. 1993; 13: 413–418.
73. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of
observational studies in epidemiology: a proposal for reporting.
Meta-analysis of Observational Studies in Epidemiology (MOOSE)
Group. Jama. 2000; 283: 2008–2012.
74. Gorber SCTM,Moher D, Gorber B. A comparison of direct vs.
self-report measures for assessing height, weight and body mass in-
dex: a systematic review. Obesity Reviews. 2007; 8: 307–326.
75. Bodnar LM, Siega-Riz AM, Simhan HN, Diesel JC, Abrams B.
The impact of exposure misclassification on associations between
prepregnancy BMI and adverse pregnancy outcomes. Obesity.
2010; 18: 2184–2190.
© 2017 The Authors. Obesity Reviews published by John Wiley & Sons Ltd
on behalf of World Obesity
Obesity Reviews 18, 293–308, March 2017
308 Maternal BMI and post-term birth N. Heslehurst et al. obesity reviews
